What Are Peptides? A Complete Guide to Getting Started

What are peptides, actually?

You typed "what are peptides" into a search bar because you kept seeing the word and nobody stopped to explain it. Fair. Here is the plain version.

A peptide is a short chain of amino acids linked end to end. Amino acids are the small building blocks your body uses to make everything from muscle to hormones to enzymes. Link a few of them together with a bond called a peptide bond, and you get a peptide. Link hundreds of them, and fold that long chain into a complex 3D shape, and you get a protein.

That is really the whole definition. Everything else in this guide is what that short chain can do once it is inside a living body.

Peptide, protein, or pill: what is the actual difference?

Three terms get mixed up constantly, so let us separate them cleanly.

A small molecule drug is tiny, usually a single compact structure you could draw on a napkin. Aspirin and ibuprofen are small molecules. They are often stable enough to survive your stomach acid, which is why so many small molecule drugs come as a pill you swallow.

A peptide sits in the middle. Research on the field describes peptides as chains of roughly 2 to 50 amino acids, bigger and more specific than a small molecule, but simpler and smaller than a full protein, according to a 2022 review in Signal Transduction and Targeted Therapy. That middle position is the whole story of why peptides matter: a peptide can be built to match a specific receptor almost like a key matches a lock, which tends to mean fewer side effects than a small molecule that bumps into several receptors at once.

A protein is the large, folded version. Insulin, antibodies, and growth hormone are proteins (insulin is sometimes called a peptide hormone because it is on the smaller end, but it still folds into a defined structure to work).

The practical difference you will notice most: peptides are usually fragile in the digestive tract. Stomach acid and gut enzymes tend to break the chain apart before it can be absorbed whole. That is why most peptides used in research and medicine are injected, applied to the skin, or given through the nose rather than swallowed as a tablet. A handful of newer oral formulations exist, but they are the exception, not the rule.

How a peptide gets made

Most research peptides today are built, not extracted. A machine adds one amino acid at a time to a growing chain, in a process called solid phase synthesis, until the full sequence is complete. That is different from how insulin was first produced, which involved purifying it from animal pancreas tissue before lab synthesis took over. Building a peptide from scratch, one link at a time, is also why the exact sequence matters so much. Change one amino acid in the chain, and you can change which receptor the peptide binds, how long it lasts in the body, or whether it does anything useful at all. Two peptides that sound almost identical in name can behave very differently once you look at their actual sequence.

A short history: peptides that already are medicine

Peptides are not a new idea. Insulin, first isolated in the 1920s, is the oldest peptide therapy still in daily use, and it remains the clearest proof that a short chain of amino acids can be both effective and safe enough for lifelong daily use. Since then, the pace has picked up considerably. A 2020 review, Peptide Therapeutics 2.0, tracks well over a hundred FDA approved peptide drug products already on the market, spanning cancer treatment, infections, hormone disorders, and metabolic disease, with new approvals arriving nearly every year. Some of the names are familiar even outside medicine, such as the GLP-1 drugs covered below. Others work quietly in specialist care, treating conditions like acromegaly, certain leukemias, or hormone sensitive cancers.

That history matters because it sets the baseline for honesty in this library. Some peptides are approved medications with a defined, tested use, years of safety monitoring, and a manufacturer accountable for quality. Most peptides that show up in research forums and supplier catalogs are not there yet, and some never will get there, because early promise in a lab does not always survive the years of human trials required for approval. Keeping that line clear is the single most important thing to understand before you read further.

The four areas where peptide research is concentrated

New peptides are being studied constantly, but almost everything you will read about clusters into four broad areas. Here is the map, with one compound as an example in each.

Weight loss and metabolic research

This is the area most people have already heard of, thanks to GLP-1 medications. Semaglutide is the active ingredient in Wegovy, and it has a specific FDA approved indication: chronic weight management in adults with obesity or overweight who also have a weight related condition, along with a separate approval to reduce cardiovascular risk in that same population, as described in the FDA's own approval announcement. Tirzepatide, sold as Mounjaro for type 2 diabetes and as Zepbound for chronic weight management, has its own FDA approval covering both uses, confirmed in the FDA's Zepbound approval notice. Both compounds work by mimicking gut hormones that signal fullness and slow digestion, which is also why the most common side effects reported in their trials involve the stomach. These two are the clearest example in the whole peptide field of a compound crossing all the way from research chemical to approved medication. Most other metabolic peptides you will encounter, including newer GLP-1 and amylin candidates still working through clinical trials, are investigational and have not cleared that bar yet.

Recovery and healing research

This category covers peptides studied for tissue repair: tendons, gut lining, muscle, and skin. BPC-157 is the compound most people ask about here. It is a synthetic sequence based on a protein found in gastric juice, and a 2021 review in PMC summarizes decades of animal research on its effects on gut healing and tissue repair, including studies on the gut, tendons, and even the nervous system. That is the key word: animal research. Human trial data on BPC-157 is limited, it has no FDA approval for any use, and it is not a legal ingredient in an approved drug. Anyone who tells you otherwise is skipping a step. TB-500, another peptide frequently discussed alongside it, follows a similar pattern: promising preclinical work, thin human data, and no approval.

Growth hormone and performance research

This category studies peptides that push the body to release more of its own growth hormone, rather than injecting growth hormone itself. CJC-1295 is a long acting version of growth hormone releasing hormone. A small human trial published in 2006 found that a single injection raised growth hormone levels for six days or more in healthy adults, an effect the researchers linked to the peptide binding tightly to a carrier protein in the blood and resisting normal breakdown. That is real human data, but it is a small, short study in healthy volunteers, not proof of long term safety or benefit in the settings people usually ask about, such as training recovery or fat loss. CJC-1295 remains a research compound with no FDA approved use, and related compounds like ipamorelin and sermorelin sit in the same category.

Longevity and wellness research

This is the newest and least settled corner of the field. Peptides here are studied for aging related outcomes: cellular stress, sleep, and general markers of wellbeing rather than a single measurable disease. Epithalon is a synthetic peptide studied mainly in early laboratory and animal work related to cellular aging, particularly the enzyme telomerase and the protective caps on the ends of chromosomes. Interest in this idea goes back decades, but the step from a laboratory finding to a proven human benefit is a long one, and it has not been completed here. Evidence in this category tends to be the earliest stage of all four, so treat any strong claim about a longevity peptide with extra skepticism, and expect the supporting studies to be smaller and shorter than what you would see for an approved drug.

Why the regulatory status matters more than the marketing

Here is the pattern worth memorizing across all four categories. A compound can be:

An approved medication, meaning it went through FDA trials for a specific condition and won approval for that specific use. Semaglutide and tirzepatide qualify, for the exact uses named above and nothing broader.

Or a research compound, meaning it is studied in labs, sometimes in animals, sometimes in small early human trials, but it has not been reviewed and approved by any regulator for human treatment. BPC-157, CJC-1295, and epithalon all fall here, along with most peptides you will see discussed anywhere online.

Neither category tells you whether something works or is safe on its own. But conflating the two, treating a research compound like it carries the same evidence and oversight as an approved drug, is the single most common way peptide information goes wrong. This library keeps that line visible in every article.

Where to go next in this library

If this is your first stop, here is a sensible order. Read how peptides work in the body next for the mechanism side of things: receptors, half life, and why injection route matters. If you already have a specific vial in hand, the reconstitution guide walks through mixing and storage. If weight loss brought you here, the GLP-1 weight loss guide goes much deeper on semaglutide, tirzepatide, and the compounds studied alongside them. Beyond that, each of the four categories above has its own pillar guide anchoring a full set of articles.

When you are ready to look at a specific compound in detail, from its research history to its studied dose ranges, the LifeConverted peptide reference library is built for exactly that, with no pressure to buy anything while you are still just learning.

Common questions

What is the difference between a peptide and a protein? Size and folding. A peptide is a short chain, usually under 50 amino acids, that mostly stays a simple strand. A protein is longer, often folds into a complex 3D shape, and needs that shape to do its job. Insulin sits right on the edge, small enough to be called a peptide hormone, structured enough to fold.

Are all peptides FDA approved? No. A small number, like semaglutide and tirzepatide, have specific FDA approved drug products for named conditions. Most compounds you will read about in this library, including BPC-157, CJC-1295, and epithalon, are investigational research chemicals, not approved medications, and they are not legal to market for human use.

Where should I start if I am new to peptides? Start with what a peptide actually is, which is this guide. From there, read how peptides move through the body, then pick the one category, weight loss, recovery, growth hormone, or longevity, that matches what you are curious about.

This article is for education only. It is not medical advice. Compounds discussed here are sold for research purposes. Talk to a licensed clinician before making health decisions.